JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
JMP Securities Upgrades CoStar Group (CSGP) to Market Outperform
-
JMP Securities Starts Fifth Street Finance (FSC) at Market Perform
-
Karyopharm Therapeutics (KPTI) Prices Upsized 2.65M Common Offering at $42.50/Share
-
Karyopharm Therapeutics Announces Pricing of Public Offering of Common Stock
-
JMP Securities Starts Five Oaks Investment (OAKS) at Market Outperform
-
Woodside Homes (WDS) Files $200M IPO
-
Karyopharm Therapeutics (KPTI) Commences 2.2M Common Stock Offering
-
Karyopharm Therapeutics Announces Proposed Public Offering of Common Stock
-
Heron Therapeutics (HRTX) Prices 4.5M Offering at $11.75/sh
-
Zogenix (ZGNX) Gains Ahead of Investor Presentation
-
JMP Securities Downgrades Teradata (TDC) to Market Perform
-
Amedica to Present at the JMP Securities Healthcare Conference
-
Innocoll AG (INNL) Files $86.25M IPO
-
Zafgen (ZFGN) IPO Opens Up 25%
-
Ardelyx (ARDX) IPO Opens Modestly Higher
-
Five Oaks Investment (OAKS) Prices 3.5M Common Offering for Net Proceeds of $38.25M
-
Ardelyx (ARDX) IPO Prices Upsized IPO at $14
-
Catalyst Pharmaceutical Partners to Present at the JMP Securities 2014 Healthcare Conference
-
Galena Biopharma to Present at the 9th Annual JMP Securities Healthcare Conference
-
Zafgen (ZFGN) Prices Upsized IPO at $16
-
Five Oaks Investment (OAKS) Falls on 3.5M Stock Offering
-
Unusual 11 Mid-Day Movers 06/18: (INSM) (MEET) (LIVE) Higher; (ECYT) (RARE) (VRS) Lower
-
Parnell Pharmaceuticals (PARN) IPO Opens Flat
-
ZIOPHARM Oncology to Present at the 9th Annual JMP Securities Healthcare Conference
-
Curis to Present at the JMP Securities Healthcare Conference
-
JMP Securities Starts Compugen (CGEN) at Market Outperform
-
Keryx Biopharmaceuticals, Inc. to Present at the 9th Annual JMP Securities Healthcare Conference
-
Cyclacel Pharmaceuticals to Present at 9th Annual JMP Securities Healthcare Conference
-
Melinta Therapeutics to Present at Annual JMP Securities Healthcare Conference
-
Cerulean Pharma to Present at JMP Securities Healthcare Conference
-
JMP Securities Starts TherapeuticsMD (TXMD) at Market Outperform
-
JMP Securities Starts Pacira Pharmaceuticals (PCRX) at Market Outperform
-
JMP Securities Starts Heritage Insurance (HRTG) at Market Outperform
-
JMP Securities Downgrades RenaissanceRe Holdings (RNR) to Market Perform
-
Parnell Pharmaceuticals (PARN) Sees IPO Price of $17 to $19/Share
-
MRI Interventions Announces Participation in Upcoming Investor Conferences
-
JMP Securities Upgrades Ocera Therapeutics (OCRX) to Market Outperform
-
JMP Securities Upgrades Edwards Lifesciences (EW) to Market Outperform
-
Notable Analyst Rating Changes 06/10: (BLT) (TWTR) (S) Upgraded; (COUP) (EHTH) (TSN) Downgraded
-
Pre-Open Stock Movers 6/10: (ACHN) (RCPT) (CHS) Higher; (RSH) (FRAN) (DNDN) Lower (more...)
-
Raptor Pharmaceutical to Participate in Three Upcoming Investor Conferences in June
-
JMP Securities Starts TrueCar (TRUE) at Market Outperform
-
JMP Securities Upgrades Achillion Pharmaceuticals (ACHN) to Market Outperform
-
JMP Securities Upgrades Idenix Pharmaceuticals Inc. (IDIX) to Market Perform
-
Notable Analyst Rating Changes 06/09: (GPRE) (ARCO) (DG) Upgraded; (BDN) (MCC) (TSLX) Downgraded
-
JMP Securities Downgrades Medley Capital (MCC) to Market Perform
-
Arista Networks (ANET) IPO Surges 32%
-
Arista Networks (ANET) IPO Prices Strong at $43
-
Intercept Pharma (ICPT) Will Present at Three Upcoming Conferences
-
Intercept to Present at Upcoming Investor Conferences

